National and international strategies set high level direction and guide the response to hepatitis C.
The fourth National Hepatitis C Strategy 2014-2017 is one of five strategies aiming to reduce sexually transmissible infections (STI) and blood borne viruses (BBV), and the morbidity, mortality and personal and social impacts they cause. (Author: Department of Health, Australian Government)
Describes how the public health system will work with general practitioners, non- government organisations, community organisations, researchers and affected communities to form a coordinated response to the hepatitis C epidemic in NSW. (Author: NSW Ministry of Health)
This action plan acknowledges the current provision of quality hepatitis C prevention, testing and treatment services within Queensland Health, the private sector and community based organisations across Queensland. (Author: Queensland Health)
This is South Australia’s plan for addressing the Fourth National Hepatitis C Strategy 2014-2017 and the Fourth National Aboriginal and Torres Strait Islander Blood Borne Viruses and Sexually Transmissible Infections Strategy 2014-2017 (Author: Department for Health and Ageing, SA Health)
The Victorian Hepatitis C Strategy 2016–2020 sets bold targets to increase prevention, testing and treatment of hepatitis C, and to reduce stigma and discrimination. (Author: Victorian Government)
The WA Hepatitis C Strategy 2015–2018 aligns with the national strategy and the Auckland Statement to address the needs of people living with, and affected by, hepatitis C in WA. (Author: WA Dept of Health)
This is the first global health sector strategy on viral hepatitis, a strategy that contributes to the achievement of the 2030 Agenda for Sustainable Development. It covers the first six years of the post-2015 health agenda, 2016–2021, building on the Prevention and Control of Viral Hepatitis Infection: Framework for Global Action, and on two resolutions on viral hepatitis adopted by the World Health Assembly in 2010 and in 2014. (Author: World Health Organisation)
The periodic evaluation of implementation of the WHO strategy requires an initial baseline survey of all Member States. In mid-2012, WHO, in collaboration with the World Hepatitis Alliance, conducted such a survey, asking Member States to provide information relating to the four axes of the WHO strategy. In particular, Member States were asked whether key prevention and control activities are being conducted. The Global policy report on the prevention and control of viral hepatitis in WHO Member States presents the results. (Author: World Health Organization (WHO); Publication Date: 2013)
Prevention and Control of Viral Hepatitis Infection: Framework for Global Action describes four areas of work to prevent, treat and save the lives of people living with hepatitis through targeted regional and country-specific strategies. Viral hepatitis remains largely undiagnosed and untreated – despite more than 500 million people affected worldwide. (Publication Date: 2012)
The National Blood Borne Virus and STI Strategy Implementation Plans have been developed to provide guidance in putting the National Blood Borne Virus and STI strategies into operation. The plans assign high-level responsibility for the priority areas identified in each strategy. To request a copy of the plans or the mid-term review, contact email@example.com. (Author: Department of Health and Ageing, Australian Government; Publication Date: 2010)
ASHM has an active program of policy development. We provide feedback on, and contribute to, policy reviews in the sector. We also develop position statements, which reflect our policy opinion on a number of clinical and non-clinical issues.
Clinical Guidelines and Policies are provided below. These are updated regularly, but if there are any Clinical Policies or Guidelines which you think should be added below, please contact us.
Hosted on www.testingportal.ashm.org.au the National Hepatitis C Testing Policy outlines current best practice for health professionals ordering and interpreting hepatitis C serology.
Bridging the Gap Between Viral Hepatitis and Liver Cancer (Europe) contains policy recommendations from the European Expert Group for Better Control of Liver Cancer, regarding the optimal management of viral hepatitis. (Author: European Expert Group for Better Control of Liver Cancer; Publication date: 2012)
The Anchorage Statement has been prepared by Indigenous peoples globally who attended the 2nd World Indigenous Peoples Conference on Viral Hepatitis held in Anchorage Alaska in August 2017. The Anchorage Statement sets out the aspirations of Indigenous peoples globally in ensuring that they are not a population left behind in global efforts to eliminate viral hepatitis by the year 2030. The statement is timely for Australia as the Commonwealth Government are embarking on the development of a new set of national strategies addressing viral hepatitis, HIV and STIs and the 5th National Aboriginal and Torres Strait Islander STI and BBV Strategy. (Publication date: September 2017)
The NSW Government is committed to reducing the sharing of injecting equipment among people who inject drugs by 25% by 2020. To assist you in being able to access your nearest NSP outlet an interactive map has been developed that contains every public NSP outlet across NSW. The map includes staffed NSPs where you can access advice, information and referral as well as machines and chutes. Visit the NSW Department of Health NSP Program Outlets page